Blood Tests in DUI Cases: Collection, Chain of Custody, and Admissibility

Blood testing in DUI prosecutions represents one of the most scientifically and legally contested forms of chemical evidence in American criminal courts. This page covers the procedural requirements for blood draw collection, the chain of custody standards that govern sample handling, and the legal standards courts apply when determining admissibility. Understanding these mechanics is essential for anyone analyzing how blood alcohol concentration evidence is introduced, challenged, or excluded at trial.

• Definition and scope
• Core mechanics or structure
• Causal relationships or drivers
• Classification boundaries
• Tradeoffs and tensions
• Common misconceptions
• Checklist or steps (non-advisory)
• Reference table or matrix

Definition and scope

A blood test in the DUI context is a chemical analysis procedure in which a biological sample is extracted from a suspect, stored under controlled conditions, and analyzed by a forensic laboratory to determine the concentration of ethanol or controlled substances present in the blood at or near the time of driving. The result is typically expressed as a blood alcohol concentration (BAC) in grams of alcohol per 100 milliliters of blood (g/dL), with 0.08 g/dL constituting the per se impairment threshold in all 50 U.S. states under each state's statutory framework (NHTSA, Traffic Safety Facts 2023).

Blood testing applies across three distinct legal scenarios: (1) post-arrest chemical testing under implied consent laws, where a driver's license constitutes advance consent to testing; (2) warrant-compelled draws authorized under the Fourth Amendment framework established in Missouri v. McNeely, 569 U.S. 141 (2013); and (3) voluntary consent draws. The scope of admissibility challenges differs significantly across these three entry points, making the circumstances of collection a threshold inquiry in any litigation involving blood evidence.

Federal highway safety standards, including those administered by the National Highway Traffic Safety Administration (NHTSA), and forensic laboratory accreditation standards from the American Society of Crime Laboratory Directors/Laboratory Accreditation Board (ASCLD/LAB) and ANSI National Accreditation Board (ANAB) set the baseline technical requirements that state laboratories are expected to meet.

Core mechanics or structure

Blood draw procedure

A legally defensible blood draw in a DUI case must satisfy three technical layers: the collection method, the personnel qualification, and the container specification.

Personnel qualification: Most state statutes restrict authorized personnel to licensed physicians, registered nurses, licensed phlebotomists, or emergency medical technicians. California Vehicle Code § 23158(a) and comparable provisions in other states enumerate qualified personnel explicitly. Draws performed by unqualified individuals are subject to suppression motions regardless of the accuracy of the result.

Antiseptic protocol: The venipuncture site must be cleaned with a non-alcohol-based antiseptic — typically povidone-iodine or benzalkonium chloride. Use of isopropyl or ethyl alcohol swabs at the draw site can artificially elevate measured BAC values, constituting a foundational challenge under Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), which governs the admissibility of scientific evidence in federal court and has been adopted in modified form by the majority of states.

Collection tubes: Gray-stopper (sodium fluoride/potassium oxalate) vacutainer tubes are the forensic standard. Sodium fluoride serves as a preservative that inhibits microbial fermentation, which can otherwise generate ethanol in the sample post-collection. Potassium oxalate functions as an anticoagulant. Failure to use proper tubes — or improper mixing by inversion (typically 8–10 inversions per manufacturer protocol) — can compromise sample integrity.

Laboratory analysis

Forensic BAC analysis in the United States is predominantly performed by headspace gas chromatography (HSGC), which the National Safety Council's Alcohol, Drugs and Impairment Division has recognized as the reference method for blood alcohol quantification. HSGC separates ethanol from other volatile compounds, reducing the risk of false positives caused by interferents such as acetone (produced endogenously in diabetics) or isopropanol.

A laboratory accredited under ANAB or ASCLD/LAB standards must run at minimum one positive control, one negative control, and one calibration standard with each analytical batch. The coefficient of variation (CV) for replicate measurements typically must remain below 5% for results to be reported.

Causal relationships or drivers

The legal admissibility of blood test results is directly contingent on the integrity of five causal chains, each capable of independently excluding evidence:

1. Constitutional authority for the draw — Missouri v. McNeely (2013) held that the natural dissipation of alcohol in the bloodstream does not automatically constitute an exigency that justifies a warrantless draw. Absent valid consent, a telephonic or written warrant is required in most circumstances. A defective warrant basis triggers suppression under the Fourth Amendment framework.

2. Qualified personnel and proper technique — Procedural deviations by unqualified collectors or use of alcohol-based antiseptics generate foundational objections.

3. Chain of custody continuity — Every transfer of the sample — from collector to transport, from transport to laboratory intake, from intake to analyst — must be documented. Gaps create reasonable doubt about whether the analyzed sample is the same sample drawn from the defendant.

4. Preservative and anticoagulant efficacy — Without adequate sodium fluoride concentration (typically 100 mg per 10 mL tube), post-draw fermentation by Candida or bacterial species can produce neo-formed ethanol, inflating reported BAC. The degree of inflation depends on initial glucose concentration, microbial load, temperature, and time. Studies published in the Journal of Analytical Toxicology have documented post-collection BAC increases of 0.01–0.05 g/dL under conditions of improper storage.

5. Laboratory analytical validity — Quality control failures, instrument calibration gaps, or analyst certification lapses can invalidate batch results. Under dui-evidence-suppression standards, defense counsel can subpoena laboratory quality assurance records under Melendez-Diaz v. Massachusetts, 557 U.S. 305 (2009), which held that forensic laboratory reports are testimonial and subject to Sixth Amendment confrontation rights.

Classification boundaries

Blood draw scenarios in DUI cases fall into four legally distinct categories that determine the applicable procedural rules:

The exigent circumstances category has narrowed substantially since McNeely. Factors courts examine include the availability of telephonic warrant procedures, time elapsed, and whether law enforcement created the exigency. A draw compelled under claimed exigency without contemporaneous documentation of the exigent circumstances faces heightened suppression risk.

For drug-impaired driving cases — addressed in the related discussion of drugged driving laws — blood is the only viable chemical test for substances such as cannabis metabolites, opioids, and benzodiazepines, because breath testing devices do not detect these compounds.

Tradeoffs and tensions

Accuracy vs. timeliness: Blood testing generally produces a more accurate BAC determination than breath testing, but requires transport to a laboratory, creating a gap between the time of driving and the time of analysis. The rising blood alcohol defense exploits this gap by arguing that BAC at the time of driving was below 0.08 g/dL even if the analyzed sample exceeds that threshold. Retrograde extrapolation — calculating backward from a known BAC to estimate BAC at an earlier time — introduces assumptions about absorption rate, distribution volume, and elimination rate (typically 0.015–0.020 g/dL/hour) that are scientifically contested.

Confrontation rights vs. laboratory efficiency: Melendez-Diaz (2009) and Bullcoming v. New Mexico, 564 U.S. 647 (2011) require that the actual analyst who performed the testing (or a qualified substitute with direct knowledge of the procedures) testify in person. This imposes significant operational costs on crime laboratories and has contributed to backlog pressures, but courts have refused to create a blanket surrogate-testimony exception.

Implied consent pressure vs. voluntary waiver standards: The Supreme Court's ruling in Birchfield v. North Dakota, 579 U.S. 438 (2016) held that states may criminalize refusal of breath tests incident to arrest without a warrant, but may not criminalize refusal of blood draws without a warrant. This creates a two-tier penalty structure that defense practitioners examine closely when challenging whether a defendant's "consent" to a blood draw was genuinely voluntary or coerced by threat of criminal refusal penalties. See the related framework under chemical test refusal.

Common misconceptions

Misconception 1: Refrigeration eliminates the need for sodium fluoride.
Refrigeration slows but does not halt microbial activity. The 2003 study published in Forensic Science International by Kugelberg and Jones documented continued ethanol production in improperly preserved samples even under refrigerated conditions. Sodium fluoride inhibition is required independent of storage temperature.

Misconception 2: Any licensed medical professional can perform a forensic blood draw.
State statutes enumerate specific categories of qualified personnel. A licensed practical nurse (LPN), for example, is qualified in some states but not others. The specific statute governing the jurisdiction of the draw — not general medical licensure — controls.

Misconception 3: A broken chain of custody automatically excludes blood test results.
Courts apply a "reasonable probability" or "weight of the evidence" standard in most jurisdictions. A gap in documentation affects the weight of the evidence and can support a suppression motion, but courts frequently admit results while permitting defense challenge to credibility. Suppression is most likely when the gap involves the sample's physical custody — not merely a missing signature on a transfer log.

Misconception 4: Gas chromatography cannot produce false positives.
HSGC can misidentify compounds that co-elute with ethanol on the chromatographic column. Dual-column analysis using columns of different polarity is the recommended protocol for eliminating co-elution artifacts. Laboratories that run single-column analysis are subject to challenge on this basis, particularly in cases involving diabetic defendants with elevated acetone or isopropanol levels.

Misconception 5: The defendant's right to an independent blood test is automatic.
Most states codify a right to obtain an independent blood sample from a qualified provider of the defendant's choosing, but that right is generally conditioned on the defendant having first submitted to the state-administered test. Independent testing is addressed in the context of dui-pretrial-motions where defendants seek to obtain laboratory records and retained sample splits.

Checklist or steps (non-advisory)

The following sequence describes the procedural stages through which a forensic blood sample passes in a DUI case. This is a descriptive reference, not legal guidance.

Stage 1 — Legal authority established
- Constitutional basis for draw confirmed (warrant, valid consent, or documented exigency)
- Implied consent advisements delivered per applicable state statute
- Refusal or consent documented contemporaneously

Stage 2 — Collection
- Qualified personnel identified and documented
- Non-alcohol antiseptic applied to venipuncture site
- Gray-stopper sodium fluoride/potassium oxalate vacutainer used
- Tube inverted 8–10 times immediately after draw
- Collection time, personnel name, and tube lot number recorded on collection form

Stage 3 — Packaging and labeling
- Sample labeled with defendant's name, date, time, collector ID, and case number
- Chain of custody form initiated with collector's signature
- Sample sealed and placed in tamper-evident packaging

Stage 4 — Transport
- Transfer to law enforcement or laboratory courier documented
- Receiving party signs chain of custody form with date and time
- Temperature control maintained during transport (typically 2–8°C refrigeration or cold pack)

Stage 5 — Laboratory intake
- Laboratory intake technician signs chain of custody form
- Sample inspected for seal integrity, label accuracy, and tube condition
- Sample logged into laboratory information management system (LIMS)
- Retained split sample stored for potential defense independent testing

Stage 6 — Analysis
- HSGC analysis performed with controls and calibrators
- Duplicate or replicate measurements taken per laboratory SOP
- Results reviewed by qualified technical reviewer
- Analytical report generated with analyst signature and LIMS batch number

Stage 7 — Reporting and disclosure
- Report transmitted to law enforcement and, upon request, defense under discovery rules
- Analyst available for testimony pursuant to Melendez-Diaz confrontation requirements
- Quality assurance records subject to defense subpoena

Reference table or matrix

Blood test challenge points and associated legal standards

References

• National Highway Traffic Safety Administration (NHTSA) — Traffic Safety Facts
• NHTSA — Model Specifications for Breath Alcohol Ignition Interlock Devices and Chemical Testing Standards
• ANSI National Accreditation Board (ANAB) — Forensic Accreditation
• American Society of Crime Laboratory Directors / Laboratory Accreditation Board (ASCLD/LAB)
• Missouri v. McNeely, 569 U.S. 141 (2013) — Supreme Court Opinion
• Birchfield v. North Dakota, 579 U.S. 438 (2016) — Supreme Court Opinion
• Melendez-Diaz v. Massachusetts, 557 U.S. 305 (2009) — Supreme Court Opinion
• Bullcoming v. New Mexico, 564 U.S. 647 (2011) — Supreme Court Opinion
• [Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993) — Supreme Court Opinion](